The proteoglycan biglycan mediates inflammatory response by activating TLR-4 in human chondrocytes: Inhibition by specific siRNA and high polymerized Hyaluronan-Reference-Cited by-同舟云学术

The proteoglycan biglycan mediates inflammatory response by activating TLR-4 in human chondrocytes: Inhibition by specific siRNA and high polymerized Hyaluronan

Published:2018-02 Issue: Volume:640 Page:75-82
ISSN:0003-9861
Container-title:Archives of Biochemistry and Biophysics
language:en
Short-container-title:Archives of Biochemistry and Biophysics

Author:

Avenoso Angela,D'Ascola Angela,Scuruchi Michele,Mandraffino Giuseppe,Calatroni Alberto,Saitta Antonino,Campo Salvatore^ORCID,Campo Giuseppe M.

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference40 articles.

1. Extracellular matrix structure;Theocharis;Adv. Drug Deliv. Rev.,2016

2. Non-proteoglycan forms of biglycan increase with age in human articular cartilage;Roughley;Biochem. J.,1993

3. The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis;Hultgardh-Nilsson;J. Intern. Med.,2015

4. Biglycan: a multivalent proteoglycan providing structure and signals;Nastase;J. Histochem. Cytochem.,2012

5. Fibrillogenesis of collagen types I, II, and IIIO with small leucine-rich proteoglycans decorin and biglycan;Douglas;Biomacromolecules,2006

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Catabolic mediators from TLR2-mediated proteoglycan aggrecan peptide-stimulated chondrocytes are reduced by Lactobacillus-conditioned media;Scientific Reports;2024-08-05

2. The Immunological Facets of Chondrocytes in Osteoarthritis: A Narrative Review;The Journal of Rheumatology;2023-11-01

3. Extracellular Matrix–Derived Damage-Associated Molecular Patterns (DAMP): Implications in Systemic Sclerosis and Fibrosis;Journal of Investigative Dermatology;2023-10

4. TNF-α Inhibitors in Combination with MTX Reduce Circulating Levels of Heparan Sulfate/Heparin and Endothelial Dysfunction Biomarkers (sVCAM-1, MCP-1, MMP-9 and ADMA) in Women with Rheumatoid Arthritis;Journal of Clinical Medicine;2022-07-20

5. siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review;Cell Biology International;2022-07-13